NEW YORK (GenomeWeb News) – BG Medicine said late on Friday it has been notified by Nasdaq for the second time in less than six months that it does not fulfill a requirement for continued listing on the exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.